Vitro Biopharma, Inc.

CIK 793171 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Vitro Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Jun 15, 202610-Q0001493152-26-028655
Mar 16, 202610-Q0001493152-26-010236
Feb 13, 202610-K0001493152-26-006592
Jan 29, 2026NT 10-K0001493152-26-004145
Sep 12, 202510-Q0001641172-25-027168
Jun 20, 202510-Q0001641172-25-015758
Jun 20, 202510-Q0001641172-25-015758
Jun 16, 2025NT 10-Q0001641172-25-015274
Jun 11, 2025D0001641172-25-014683
Mar 20, 202510-Q0001493152-25-011003
Mar 17, 2025NT 10-Q0001493152-25-010585
Jan 28, 202510-K0001493152-25-003942
Sep 16, 202410-Q0001493152-24-036326
Sep 11, 2024EFFECT9999999995-24-002788
Sep 5, 2024S-1/A0001493152-24-035112
Aug 23, 2024S-1/A0001493152-24-033726
Aug 8, 2024S-1/A0001493152-24-030726
Jul 22, 20248-K0001493152-24-028669
Jul 1, 2024S-1/A0001493152-24-025754
Jun 27, 20248-K0001493152-24-025334
May 31, 202410-Q0001493152-24-022030
May 17, 20248-K0001493152-24-020410
Apr 17, 20248-K0001493152-24-015061
Mar 14, 202410-Q0001493152-24-009929
Feb 2, 2024S-1/A0001493152-24-004779